Gene: CDV3
Official Full Name: CDV3 homologprovided by HGNC
Gene Summary: Located in cytosol and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO02524 | CDV3 Knockout cell line (HeLa) | Human | CDV3 | 1:3~1:6 | Negative | Online Inquiry |
KO02525 | CDV3 Knockout cell line (HCT 116) | Human | CDV3 | 1:2~1:4 | Negative | Online Inquiry |
KO02526 | CDV3 Knockout cell line (HEK293) | Human | CDV3 | 1:3~1:6 | Negative | Online Inquiry |
KO02527 | CDV3 Knockout cell line (A549) | Human | CDV3 | 1:3~1:4 | Negative | Online Inquiry |
CDV3 Gene Knockout Cell Lines are meticulously developed cellular models that enable researchers to investigate the functional role of the CDV3 gene by inactivating it through targeted gene editing techniques. These cell lines are essential tools in molecular biology, designed to facilitate studies on gene function, cellular pathways, and disease mechanisms associated with the CDV3 gene. By utilizing CRISPR/Cas9 technology, the functionality of the CDV3 gene is disrupted, allowing scientists to explore its molecular interactions and downstream effects on cellular physiology.
The primary mechanism of action involves single-guide RNA (sgRNA) designed to specifically target the CDV3 locus, leading to the introduction of insertions or deletions (indels) that result in a frameshift mutation. This knockout methodology serves as a foundation for various experimental approaches, including gene expression analysis, protein interaction studies, and pathway elucidation. The availability of these knockout cell lines significantly enhances the precision with which researchers can assess the contributions of the CDV3 gene to health and disease.
Scientifically, CDV3 gene knockout cell lines hold substantial importance in both basic and applied research realms. They are invaluable for drug discovery, genetic screening, and the development of therapeutic strategies, particularly in understanding disorders where the CDV3 gene is implicated. In clinical settings, these cell lines can aid in personalized medicine approaches, allowing for tailored treatments based on genetic backgrounds.
When comparing CDV3 Gene Knockout Cell Lines to other alternatives, the precision of our knockout mechanisms stands out, ensuring high efficiency and specificity in gene disruption. Additionally, our cell lines are optimized for growth and experimentation, providing a consistent platform for various research applications. With a focus on rigorous validation and reproducibility, our product offers significant advantages over standard knockout models, including reduced off-target effects and enhanced physiological relevance.
Ultimately, the CDV3 Gene Knockout Cell Lines represent a potent resource for researchers and clinicians seeking to advance their understanding of gene function and its role in health and disease. By leveraging our deep expertise in genetic engineering and cell line development, we are committed to delivering high-quality biological products that empower scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.